Suvorexant in Insomnia Co-morbid With Fibromyalgia
Status:
Terminated
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This study will compare sleep, pain and daytime sleepiness/fatigue in people with insomnia
co-morbid with fibromyalgia while treated short-term with suvorexant 20 mg versus placebo.